A-ME/CFS subjects who developed malignancies (n=8) had higher levels of IL5, CSF2 and PDGFBB than other A-ME/CFS subjects (Supplementary Table S2). Here, CSF2 is linked to myalgic encephalomeyelitis/chronic fatigue syndrome.